|

Misleading Symptoms: The Complex Path to Diagnosing Mesothelioma

Misleading Symptoms: The Complex Path to Diagnosing Mesothelioma

Patients with symptoms that look like mesothelioma take longer to get an accurate diagnosis, finds a study out of the United Kingdom.

The Complex Path to Diagnosing Mesothelioma

Mesothelioma is a rare form of cancer that develops from the cells in the lining of many of the internal organs in the body. There are about 2,000 cases of mesothelioma diagnosed in the United States each year. It is caused by exposure to asbestos.

Symptoms of mesothelioma may include shortness of breath, chest pain, weight loss, and fatigue. These are so like many other diseases that only a proper work-up, including scans and even a biopsy, can determine if the cause is mesothelioma. Because the disease is so rare, it can take a long time for a doctor to finally diagnose mesothelioma in someone.

Prolonged Diagnosis Times for Mesothelioma Look-Alikes

The researchers looked at patients who were at least 65 years old in 2019 and had been diagnosed with either lung cancer or mesothelioma. They looked at how long it took from when the patients first showed symptoms to when they were officially diagnosed. They also took other factors into account, like how often the patients saw their doctors, if they smoked, and their body mass index.

They found that patients with other health conditions that look like lung cancer or mesothelioma took longer to get an accurate diagnosis. It increased the time it took to get an accurate diagnosis by up to 72 days.

The researchers also discovered that the more competing conditions a person had, the longer the delay.

Delays in diagnosis make it harder to successfully treat patients with mesothelioma because the delay gives the cancer more time to spread. The more a cancer can spread, the harder it is to remove it from the patient’s body completely. This means that more invasive treatment methods are needed, which can be hard or even impossible for the patient to undergo.

Doctors should be encouraged to consider mesothelioma whenever symptoms present themselves in a patient. This can improve the time to diagnosis and make it easier to treat this aggressive disease.

Source

Rogers I, Cooper M, Memon A, Ford E. The effect of comorbidities on diagnostic interval for lung cancer and mesothelioma: A cohort study using linked data from the Clinical Practice Research Datalink and Cancer Registry. International Journal of Population Data Science. 2023;8(3):60. https://ijpds.org/article/view/2241/4846.

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • |

    Mesothelioma Still Carries Heavy Mortality Burden in U.S.

    Asbestos exposure cost Americans more than 427,000 years of potential life in the first decade of the new millennium. That figure comes from a study on mesothelioma and asbestosis – the two most deadly asbestos-related diseases – conducted by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Using National Center for Health Statistics mortality data, NIOSH researchers evaluated premature deaths and “loss of potentially productive years of life” attributable to either asbestosis or mesothelioma between 1999 and 2010. The data included only people 25 years or older with an underlying cause of death listed on their death certificate of either asbestosis or malignant mesothelioma. When the figures were calculated using the normal life expectancy for each asbestosis victim…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • |

    Mesothelioma Rates Expected to Rise for Another Decade

    Most developed countries can expect another decade or more of rising mesothelioma rates before the incidence of the disease starts to wane. That is one of the major findings in a recent report from The Baird Institute for Applied Heart and Lung Surgical Research in Australia. The report, which looked at the causes, distribution and projected future incidence of malignant mesothelioma, contains both good and bad news for the U.S.. Mesothelioma is an aggressive and often fatal cancer caused by exposure to asbestos.  It is thought to be triggered by chronic inflammation and irritation in the lung tissue and the surrounding pleural membrane by the sharp asbestos fibers.   Mesothelioma often takes decades to develop. According to the Baird Institute report, the average…

  • |

    Peritoneal Mesothelioma Study: Long-Term Survival is Possible

    A new study out of Italy has some encouraging news for patients with the peritoneal form of malignant mesothelioma. The recent analysis of 108 peritoneal mesothelioma patients who underwent complete cytoreductive surgery (CRS) followed by a rinse of heated chemotherapy (HIPEC) found a 43.6% cure rate among long-term survivors. Peritoneal mesothelioma is a rare form of one of the rarest cancers. Triggered almost exclusively by exposure to asbestos, mesothelioma affects about 2,500 Americans each year.  About a third of those patients are diagnosed with the peritoneal form of the disease, which occurs on the membrane that lines the abdomen and surrounds the internal organs. During cytoreductive surgery, surgeons attempt to remove all traces of the mesothelioma tumor so that no cells…